Your browser doesn't support javascript.
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
Romani, Lorenza; Del Chierico, Federica; Macari, Gabriele; Pane, Stefania; Ristori, Maria Vittoria; Guarrasi, Valerio; Gardini, Simone; Pascucci, Giuseppe Rubens; Cotugno, Nicola; Perno, Carlo Federico; Rossi, Paolo; Villani, Alberto; Bernardi, Stefania; Campana, Andrea; Palma, Paolo; Putignani, Lorenza.
  • Romani L; Infectious Disease Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Del Chierico F; Multimodal Laboratory Medicine Research Area, Unit of Human Microbiome, IRCCS, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Macari G; GenomeUp SRL, Rome, Italy.
  • Pane S; Department of Diagnostic and Laboratory Medicine, Unit of Microbiology and Diagnostic Immunology, Unit of Microbiomics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Ristori MV; Multimodal Laboratory Medicine Research Area, Unit of Human Microbiome, IRCCS, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Guarrasi V; GenomeUp SRL, Rome, Italy.
  • Gardini S; GenomeUp SRL, Rome, Italy.
  • Pascucci GR; Research Unit of Congenital and Perinatal Infections, Bambino Gesu` Children's Hospital, IRCCS, Rome, Italy.
  • Cotugno N; Research Unit of Congenital and Perinatal Infections, Bambino Gesu` Children's Hospital, IRCCS, Rome, Italy.
  • Perno CF; Chair of Pediatrics, Department of Systems Medicine, University of Rome ''Tor Vergata'', Rome, Italy.
  • Rossi P; Department of Diagnostic and Laboratory Medicine, Unit of Microbiology and Diagnostic Immunology, Multimodal Laboratory Medicine Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Villani A; Chair of Pediatrics, Department of Systems Medicine, University of Rome ''Tor Vergata'', Rome, Italy.
  • Bernardi S; Academic Department of Pediatrics, Bambino Gesu` Children's Hospital, IRCCS, Rome, Italy.
  • Campana A; Pediatric Emergency Department and General Pediatrics, Children Hospital Bambino Gesù, IRCCS, Rome, Italy.
  • Palma P; Infectious Disease Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Putignani L; Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Front Cell Infect Microbiol ; 12: 908492, 2022.
Article in English | MEDLINE | ID: covidwho-2154671
ABSTRACT
This is the first study on gut microbiota (GM) in children affected by coronavirus disease 2019 (COVID-19). Stool samples from 88 patients with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and 95 healthy subjects were collected (admission 3-7 days, discharge) to study GM profile by 16S rRNA gene sequencing and relationship to disease severity. The study group was divided in COVID-19 (68), Non-COVID-19 (16), and MIS-C (multisystem inflammatory syndrome in children) (4). Correlations among GM ecology, predicted functions, multiple machine learning (ML) models, and inflammatory response were provided for COVID-19 and Non-COVID-19 cohorts. The GM of COVID-19 cohort resulted as dysbiotic, with the lowest α-diversity compared with Non-COVID-19 and CTRLs and by a specific ß-diversity. Its profile appeared enriched in Faecalibacterium, Fusobacterium, and Neisseria and reduced in Bifidobacterium, Blautia, Ruminococcus, Collinsella, Coprococcus, Eggerthella, and Akkermansia, compared with CTRLs (p < 0.05). All GM paired-comparisons disclosed comparable results through all time points. The comparison between COVID-19 and Non-COVID-19 cohorts highlighted a reduction of Abiotrophia in the COVID-19 cohort (p < 0.05). The GM of MIS-C cohort was characterized by an increase of Veillonella, Clostridium, Dialister, Ruminococcus, and Streptococcus and a decrease of Bifidobacterium, Blautia, Granulicatella, and Prevotella, compared with CTRLs. Stratifying for disease severity, the GM associated to "moderate" COVID-19 was characterized by lower α-diversity compared with "mild" and "asymptomatic" and by a GM profile deprived in Neisseria, Lachnospira, Streptococcus, and Prevotella and enriched in Dialister, Acidaminococcus, Oscillospora, Ruminococcus, Clostridium, Alistipes, and Bacteroides. The ML models identified Staphylococcus, Anaerostipes, Faecalibacterium, Dorea, Dialister, Streptococcus, Roseburia, Haemophilus, Granulicatella, Gemmiger, Lachnospira, Corynebacterium, Prevotella, Bilophila, Phascolarctobacterium, Oscillospira, and Veillonella as microbial markers of COVID-19. The KEGG ortholog (KO)-based prediction of GM functional profile highlighted 28 and 39 KO-associated pathways to COVID-19 and CTRLs, respectively. Finally, Bacteroides and Sutterella correlated with proinflammatory cytokines regardless disease severity. Unlike adult GM profiles, Faecalibacterium was a specific marker of pediatric COVID-19 GM. The durable modification of patients' GM profile suggested a prompt GM quenching response to SARS-CoV-2 infection since the first symptoms. Faecalibacterium and reduced fatty acid and amino acid degradation were proposed as specific COVID-19 disease traits, possibly associated to restrained severity of SARS-CoV-2-infected children. Altogether, this evidence provides a characterization of the pediatric COVID-19-related GM.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastrointestinal Microbiome / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Child / Humans Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.908492

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Gastrointestinal Microbiome / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Child / Humans Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.908492